Cardiovascular diseases are the leading cause of death throughout China. In an effort to reverse this trend, the ACC has a long history of working with partner societies and other stakeholders in China to optimize patient care and outcomes through targeted education and the sharing of research and best practices. Check out some of ACC's recent China-based efforts below, and be sure to follow ACC on WeChat for updates and resources in Mandarin.

COVID-19 Front Line Experience and Clinical Perspectives | China

  • JACC research and ACC.org news stories
  • ACC/Chinese Cardiovascular Association COVID-19 Webinar Series
  • Insight From Wuhan COVID-19 Front Line Clinicians: ACC YouTube Series
  • Cardiology Magazine coverage
  • More

Translated "Key Questions on COVID-19 and Cardiovascular Disease" FAQ Document: Chinese (Mandarin) 

CardioSmart
CardioSmart helps support, inform and connect patients with their cardiologist and health care team – giving them tools and resources to partner together and personalize care. Learn more and view CardioSmart patient resources in Chinese.

The Journal of the American College of Cardiology

ACC's China and US Hospital Partnership Program: April 2020 Newsletter Edition

ACC's China and US Hospital Partnership Program: May 2020 Newsletter Edition

ACC's China and US Hospital Partnership Program: July 2020 Newsletter Edition

ACC's China and US Hospital Partnership Program: August 2020 Newsletter Edition

ACC's China and US Hospital Partnership Program: October 2020 Newsletter Edition

ACC.20 Together With World Congress of Cardiology Virtual

ESC Congress 2020 – The Digital Experience

The Global Heart Attack Treatment Initiative (GHATI)

Be sure to follow ACC on WeChat for updates and resources in Mandarin.